Search results
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 3 hours agoSource: Author's elaboration, based on GuruFocus data. Novo Nordisk's trailing 12-month non-GAAP price-earnings ratio is 45.3, indicating it is trading...
Tesla stock boosts the market to start a busy week of Fed meetings and earnings
Quartz· 2 hours agoThe list of companies reporting earnings this week includes Apple, Amazon, Advanced Micro Devices,...
Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY): Anti-Obesity Drug Market Could Reach Double...
The Wall Street Transcript· 17 hours agoCiti Research Health Care Analyst Andrew Baum, M.D., maintains a “buy” recommendation on GLP-1...
Dow Jones Futures Rise: Nvidia Leads New Buys; Tesla Runs Past Resistance On Elon Musk Move
Investor's Business Daily· 5 hours agoExpect strong growth thanks to booming demand for the weight-loss drugs. Investors will be looking...
Weight Loss Leader Novo Nordisk Hits Buy Trigger In Stock Market Rebound
Investor's Business Daily· 5 days agoWednesday's IBD 50 Stocks To Watch pick, weight-loss drug leaderNovo Nordisk, hit an early buy...
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks
Motley Fool via Yahoo Finance· 5 hours agoA good way to spot trends in the stock market is to look at which companies asset management firms...
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. | The Motley Fool
The Motley Fool· 5 days agoGood news could be just around the corner for two drugmakers not named Novo Nordisk.
Stocks to watch this week: Amazon, Apple, Anglo American and Novo Nordisk
Yahoo Finance UK· 3 days agoIn Europe, the continent's most valuable company Novo Nordisk will show if it still reigns supreme....
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance· 5 days agoIn the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the...
Novo Nordisk under Senate probe over Wegovy pricing
Seeking Alpha· 5 days agoA key Senate committee on Wednesday announced an investigation into Novo Nordisk's (NVO) pricing of weight loss drug semaglutide in the US. Read more...
